Moxibustion for Mild and Moderate Ulcerative Colitis

Shanghai Institute of Acupuncture, Moxibustion and Meridian

Status: Completed

Conditions: Ulcerative Colitis

Treatments: Other: herb-partitioned moxibustion; Other: bran-partitioned moxibustion

Study type: Interventional

Funder types: Other

Identifiers

NCT02084186

81303033

Details and patient eligibility

About

The purpose of this study is to determine whether moxibustion is effective to mild and moderate ulcerative colitis and the effect of moxibustion on metabolism.

Enrollment: 60 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Meet the diagnosis of UC
• Mayo ≤10
• Patients should have never received any pharmacological therapy or if they are receiving aminosalicylates and/or prednisolone (the dosage has been taken at least 4 weeks, and should be kept the same as before throughout the trial)
• Patients should have never received antibiotic, biologicals, probiotics, acetaminophen, acetamide and contraceptive.
• A written informed consent

Exclusion criteria

• Patients with cardiac, encephalic, hepatic, nephric, hematopoietic system, psychotic or any other serious diseases
• Pregnancy or lactation

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups, including a placebo group

moxibustion group

Experimental group

Description:

herb-partitioned moxibustion on bilateral Tianshu (ST25) and Shangjuxu (ST37)

Treatment:

Other: herb-partitioned moxibustion

bran-partitioned moxibustion

Placebo Comparator group

Description:

bran-partitioned moxibustion on bilateral Tianshu (ST25) and Shangjuxu (ST37)

Treatment:

Other: bran-partitioned moxibustion